At few other times in history has so much fear been generated globally as in 2020 and 2021, and the depth and breadth of the strategies used to stoke these fears is overwhelming.
Effective Treatment Strategies Have Been Censored
Emergency approvals for drugs that have not been proven effective in trials, public mask orders for which there is no scientific evidence, and suppression and censorship of health information have fueled public fear of a viral disease with a survival rate of over 99%.
Unfortunately, many of the first effective treatment strategies that can be used at home have also fallen victim to censorship. Ivermectin is one of these strategies. In a computerized analysis of the Omikron variant compared to several therapeutic agents, the data show that ivermectin produces the best results.
However, looking objectively at what is happening around the world, the fear being generated is not one-sided. The suppression of information by companies, government agencies and the pharmaceutical industry is indicative of their concern and how far they are willing to go to ensure that fear levels remain high enough to manipulate behavior.
Consider the statistics from the U.S. Centers for Disease Control and Prevention. In 2019, 4.6% of the U.S. population was diagnosed with heart disease. The population at the end of 2019 was 328,239,523, meaning there were 15,099,018 people with heart disease in the U.S. in 2019. That year, 696,962 people died from heart disease, which is a 4.6% mortality rate.
This is 20 times higher than the death rate from COVID-19. Yet, these same authorities did not advocate banning sodas or sugary foods; they did not ban smoking or mandate exercise – all risk factors for heart disease.
Censorship and suppression of information has hindered early treatment of COVID-19 in many Western countries. By 2020, health experts and the mainstream media warned against the use of hydroxychloroquine and ivermectin. Both are on the World Health Organization (WHO) list of essential medicines, but the benefits have been ignored by health authorities and concealed by the media.
Recent Ivermectin Study Shows Best Results Against COVID
This study, published on Cornell University’s Preprint website, has not yet been peer-reviewed. The researchers used computer-assisted analysis to examine the Omikron variant, which is characterized by lower clinical incidence and lower hospitalization rates.
After retrieving the full genome sequence and collecting 30 variants from the database, the researchers analyzed 10 drugs against the virus, including:
- MPro 13b
- MPro N3
The researchers found that each of the drugs had some degree of efficacy against the virus, and most were currently in clinical trials. Using molecular docking, they found that mutations in the omicron variant did not significantly affect the interaction between the drugs and the major protease.
Analysis of all 10 drugs showed that ivermectin was the most effective drug candidate against the omicron variant. The tests also included nirmatrelvir (paxlovid), the new protease inhibitor for which the FDA granted emergency approval against COVID in December 2021.
In other words, Pfizer launched a new drug that cost U.S. taxpayers $5.29 billion, or $529 per course of treatment, and for which an EUA was granted, despite the availability of a similar drug that has been shown to be more effective and is cheaper, costing between $4820 and $9521 for 20 tablets, depending on location.
How Ivermectin works
Ivermectin is best known for its antiparasitic properties. However, the drug also has antiviral and anti-inflammatory properties. Studies have shown that ivermectin helps lower viral load by inhibiting replication. A single dose of ivermectin can kill 99.8% of the virus within 48 hours.
A meta-analysis in the American Journal of Therapeutics found that the drug reduces infection by an average of 86% when used preventively. An observational study in Bangladesh evaluated the efficacy of ivermectin for prophylaxis of COVID-19 in healthcare workers.
The data showed that four of the 58 volunteers who took 12 mg of ivermectin once a month for four months developed mild COVID symptoms, compared with 44 of the 60 healthcare workers who refused the drug.
Ivermectin has also been shown to speed recovery by inhibiting inflammation and protecting against organ damage. In this way, it also reduces the risk of hospitalization and death. Meta-analyses have shown an average reduction in mortality of between 75%28 and 83%.
In addition, the drug also prevents transmission of SARS-CoV-2 when taken before or after exposure. Taken together, these benefits make it clear that ivermectin could almost eliminate this pandemic.
Early intervention Reduces Long COVID and Hospital Stays
Some people who have COVID-19 seem unable to fully recover and complain of persistent symptoms of chronic fatigue. Others struggle with mental health issues. A November 2020 study found that 18.1% of COVID-19 patients received their first psychiatric diagnosis in the 14 to 90 days after recovery. The most commonly diagnosed conditions were anxiety disorders, insomnia, and dementia.
These symptoms are also referred to as long COVID, long COVID, post-COVID syndrome, chronic COVID, or long COVID syndrome. All of these terms refer to symptoms that continue for four weeks after an initial COVID-19 infection.
According to Dr. Peter McCullough, an internal medicine specialist and cardiologist, 50% of those who have been sick enough to be hospitalized have symptoms of long COVID:
The sicker someone is and the longer their COVID lasts, the more likely they are to have long COVID syndrome. That’s the reason we prefer early treatment. We shorten the duration of symptoms and the likelihood of Long COVID syndrome is lower.
Common symptoms of Long COVID syndrome include shortness of breath, joint pain, memory, concentration or sleep problems, muscle pain or headaches, and loss of smell or taste.
According to McCullough, a paper presented by Dr. Bruce Patterson at the International COVID Summit in Rome, Sept. 11-14, 2021 :
…showed that in individuals who have undergone severe COVID disease, the s1 segment of the spike protein is recoverable from human monocytes 15 months later. That is, the body has literally been sprayed with the virus and spends 15 months, so to speak, removing the spike protein from our tissues. No wonder people have a long COVID syndrome.
It should come as no surprise that studies have also confirmed that early intervention improves mortality rates and reduces hospitalizations. Perhaps one of the greatest crimes in this entire pandemic has been the refusal of the prevailing health authorities to issue guidelines for early treatment.
Instead, they have done everything they can to suppress remedies that have been shown to be effective. Patients have simply been told to stay home and do nothing. Once the infection worsened to the point of near death, patients were instructed to go to the hospital, where most were routinely given mechanical ventilation – a practice that quickly proved fatal.
However, as the study presented and other studies have shown, ivermectin is one of the successful treatment protocols that can be used against SARS-CoV-2.
Africa has lowest case and death rate, likely due to ivermectin
Countries around the world have taken different steps to contain the spread of the virus. In Africa, different steps have been taken depending on the country, but infection and death rates have been relatively stable and low across the continent.
In the past year, there have been reports of small areas around the world where the number of infections, deaths, or mortality rates have been significantly lower than in the rest of the world. For example, the Indian state of Uttar Pradesh reported a cure rate of 98.6% and no other infections.
However, the entire African continent appears to have dodged the massive number of infections and deaths predicted for these poorly funded countries with crowded cities. Earlier estimates suggested that millions of people would die, but that scenario has not materialized. The World Health Organization called Africa “one of the least affected regions in the world.”
There are several factors that can affect infection rates in Africa. A study from Japan shows that after only 12 days of allowing doctors to legally prescribe ivermectin to their patients, cases dropped dramatically.
The chairman of the Tokyo Medical Association was struck by the low number of infections and deaths in Africa, where many use ivermectin prophylactically and as a main strategy for treating onchocerciasis, a parasitic disease also known as river blindness. More than 99% of people infected with river blindness live in 31 African countries.
In addition to ivermectin, other drugs used in Africa include hydroxychloroquine and chloroquine, which have long been used to treat and prevent malaria, which is also endemic in Africa. In America, Dr. Vladimir Zelenko has published successful results with hydroxychloroquine and zinc against COVID-19.
Artemisia annua, also known as sweet wormwood, is an herb used in combination therapies to treat malaria. It has been used in traditional Chinese medicine for more than 2,000 years to treat fever. Today, artemisinin, a metabolite of Artemisia, is the current therapeutic option for malaria. Since the SARS outbreak in 2003, the plant has also been studied for the treatment of coronavirus – with good results.
In other words, whether intentionally or not, the drugs that have proven successful against the virus are often used in Africa for other diseases as well. While Pfizer tests the short- and long-term effects of a genetic experiment on the Israeli population, one continent appears to have proven that administering a 30-year-old, inexpensive drug with a known safety profile could reduce the cases, severity and mortality of this infection.
The question that needs to be asked and answered to get to the bottom of this planemic is: what is preventing the mainstream media, government agencies, health experts, medical associations, doctors, nurses, and your neighbors from recognizing and advocating for the science?
44. WHO, Malaria